SOFT TISSUE SARCOMA (STS)
Clinical trials for SOFT TISSUE SARCOMA (STS) explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA (STS) trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA (STS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation method aims to boost tumor fight in sarcoma patients
Disease control Recruiting nowThis study compares a new type of radiation therapy (SFRT) to standard radiation for people with large soft tissue sarcomas (tumors at least 5 cm). About 106 participants will be randomly assigned to one of the two treatments. The goal is to see if SFRT can shrink tumors better a…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 16, 2026 23:19 UTC
-
New pill shows promise in slowing rare Cancer's growth
Disease control Recruiting nowThis study tests an experimental oral drug called cirtuvivint for people with advanced soft-tissue sarcoma that has not responded to prior treatment. About 25 participants in Spain will take the drug to see if it can stop or slow cancer growth for at least 3 months. The drug targ…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New imaging tracer lights up tumors in first human tests
Knowledge-focused Recruiting nowThis early-phase study is testing a new radioactive imaging agent in 32 adults with various solid tumors. The goal is to see how the agent spreads through the body and whether it can highlight tumors on PET/CT scans. Participants receive a single injection of the agent and underg…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: EARLY_PHASE1 • Sponsor: Var2 Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC